News

Will Private Equity Be Able to Gain Enough Retail Capital to Maintain Its Growth?
Plus, how fund managers are balancing different levels of liquidity of private market assets as the landscape evolves.
BMO Capital Maintains a Buy on Prime Medicine (PRME), Sets a $10 PT
Prime Medicine Inc. (NASDAQ:PRME) is one of the hot penny stocks to invest in now. On July 16, BMO Capital analyst Kostas Biliouris maintained a Buy rating on Prime Medicine Inc. (NASDAQ:PRME) and set ...